Champions Oncology is engaged in drug discovery and development through research strategies and pharmacology, biomarker and data platforms. Co.'s research services utilize its research center to assist pharmaceutical and biotechnology companies with their drug development process. Co.'s Software as a service business is centered around its proprietary software platform and data tool, Lumin Bioinformatics, which contains information derived from its research services and clinical studies. Co.'s drug discovery and development business utilizes the computational and experimental capabilities within its platforms. The CSBR stock yearly return is shown above.
The yearly return on the CSBR stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the CSBR annual return calculation with any dividends reinvested as applicable (on ex-dates).
|